chitosan has been researched along with cyclin d1 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, SJ; Gritsanapan, W; Rojanapanthu, P; Silva, G; Sukamporn, P; Zhang, X | 1 |
| Chanchai, S; Chatsudthipong, V; Mattaveewong, T; Muanprasat, C; Pichyangkura, R; Wongkrasant, P | 1 |
| Gonil, P; Iempridee, T; Pimtong, W; Ruktanonchai, UR; Sajomsang, W; Suktham, K; Surassmo, S; Yostawonkul, J | 1 |
| Chang, HI; Chang, SF; Chen, CN; Cheng, CC; Huang, KC; Lee, KC; Su, YP | 1 |
| Isabella, S; Mirunalini, S | 1 |
| Choi, DH; Huh, KM; Joo, C; Kang, SW; Lee, KE; Park, YS | 1 |
| Ahn, CB; Je, JY; Marasinghe, MPCK; Oh, Y | 1 |
7 other study(ies) available for chitosan and cyclin d1
| Article | Year |
|---|---|
Damnacanthal and its nanoformulation exhibit anti-cancer activity via cyclin D1 down-regulation.
Topics: Anthraquinones; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Chitosan; Cyclin D1; Dose-Response Relationship, Drug; Down-Regulation; Drug Compounding; Excipients; Gene Expression Regulation, Neoplastic; Humans; Morinda; Nanoparticles; Protein Processing, Post-Translational | 2016 |
Chitosan oligosaccharide suppresses tumor progression in a mouse model of colitis-associated colorectal cancer through AMPK activation and suppression of NF-κB and mTOR signaling.
Topics: AMP-Activated Protein Kinases; Animals; Anticarcinogenic Agents; Chitosan; Colitis; Colon; Colorectal Neoplasms; Cyclin D1; Disease Models, Animal; Male; Matrix Metalloproteinase 9; Mice, Inbred C57BL; NF-kappa B; Oligosaccharides; TOR Serine-Threonine Kinases; Tumor Burden | 2016 |
Surface modification of nanostructure lipid carrier (NLC) by oleoyl-quaternized-chitosan as a mucoadhesive nanocarrier.
Topics: Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Caco-2 Cells; Cell Survival; Chitosan; Cyclin D1; Cyclin-Dependent Kinase 4; Drug Carriers; Drug Compounding; Drug Liberation; Gene Expression; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; Nanoparticles; Particle Size; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Surface Properties; Xanthones | 2017 |
Glucose adsorption to chitosan membranes increases proliferation of human chondrocyte via mammalian target of rapamycin complex 1 and sterol regulatory element-binding protein-1 signaling.
Topics: Adaptor Proteins, Signal Transducing; Adsorption; Aged; Antirheumatic Agents; Cell Culture Techniques; Cell Line; Cell Proliferation; Chitosan; Chondrocytes; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Fatty Acid Synthase, Type I; Female; Glucose; Humans; Male; Mechanistic Target of Rapamycin Complex 1; Membranes, Artificial; Middle Aged; mTOR Associated Protein, LST8 Homolog; Multiprotein Complexes; Osteoarthritis; Protein Kinase Inhibitors; Regulatory-Associated Protein of mTOR; RNA Interference; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Time Factors; TOR Serine-Threonine Kinases; Transfection | 2017 |
3, 3'-Diindolylmethane-encapsulated chitosan nanoparticles accelerate molecular events during chemical carcinogen-induced mammary cancer in Sprague Dawley rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Carcinogens; Chitosan; Cyclin D1; Female; Gene Expression Regulation, Neoplastic; Indoles; Mammary Neoplasms, Experimental; Nanoparticles; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley | 2019 |
Octanoyl glycol chitosan enhances the proliferation and differentiation of tonsil-derived mesenchymal stem cells.
Topics: Cell Cycle; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chitosan; Cyclin D1; Humans; Mesenchymal Stem Cells; Osteogenesis; Oxygen Consumption; Palatine Tonsil; Polymers; Tissue Engineering; Wound Healing | 2021 |
Insertion of gallic acid onto chitosan promotes the differentiation of osteoblasts from murine bone marrow-derived mesenchymal stem cells.
Topics: Animals; beta Catenin; Cell Differentiation; Chitosan; Collagen Type I; Cyclin D1; Gallic Acid; Magnetic Resonance Spectroscopy; Mesenchymal Stem Cells; Mice; Osteoblasts | 2021 |